All data are based on the daily closing price as of March 18, 2026
i
Ildong Pharmaceutical
249420.KO
22.08 USD
0.08
+0.36%
Overview
Last close
22.08 usd
Market cap
695.66M usd
52 week high
30.05 usd
52 week low
7.11 usd
Target price
33.61 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.7953
Price/Book Value
4.4461
Enterprise Value
757.86M usd
EV/Revenue
1.9588
EV/EBITDA
18.9304
Key financials
Revenue TTM
393.96M usd
Gross Profit TTM
148.79M usd
EBITDA TTM
26.98M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
409.71M usd
Net debt
56.91M usd
About
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.